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Background: Several aspects of herpes simplex virus ICP27 trafficking remain unclear.
Results: We investigated if ICP27 could interact with the nuclear pore complex, finding that ICP27 directly binds the core
nucleoporin Nup62.
Conclusion: ICP27 association with Nup62 may provide additional binding sites at the pore for ICP27 shuttling.
Significance: We propose that ICP27 competes with some transport receptors, resulting in inhibition of host pathways and
supporting ICP27-mediated transport of HSV-1 mRNAs.
The herpes simplex virus ICP27 protein is important for the
expression andnuclear export of viralmRNAs.Although several
binding sites have been mapped along the ICP27 sequence for
various RNA and protein partners, including the transport
receptor TAP of the host cell nuclear transport machinery, sev-
eral aspects of ICP27 trafficking through the nuclear pore com-
plex remain unclear. We investigated if ICP27 could interact
directly with the nuclear pore complex itself, finding that ICP27
directly binds the core nucleoporin Nup62. This is confirmed
through co-immunoprecipitation and in vitro binding assays
with purified components. Mapping with ICP27 deletion and
point mutants further shows that the interaction requires
sequences in both the N and C termini of ICP27. Expression of
wild type ICP27 protein inhibited both classical, importin /-
dependent and transportin-dependent nuclear import. In con-
trast, an ICP27 point mutant that does not interact with Nup62
hadno such inhibitory effect.We suggest that ICP27 association
withNup62provides additional binding sites at the nuclear pore
for ICP27 shuttling, thus supporting ICP27-mediated transport.
We propose that ICP27 competes with some host cell transport
receptors for binding, resulting in inhibition of those host trans-
port pathways.
Herpesvirus replication involves a highly regulated temporal
cascade of gene expression that depends greatly on the host cell
nuclear pore complex (NPC)6 (1). Initially, the NPC is used for
nuclear import of the viral genome (2). Then, when the virus
lytic infection cycle proceeds, immediate early herpesvirus
mRNAs are exported from the nucleus to make the immediate
early proteins in the cytoplasm that must be imported into the
nucleus to activate the early genes that in turn are exported as
mRNAs to make the early proteins, and this cycle repeats again
for late genes and the late proteins (reviewed in Ref. 3).
The NPCs are the cellular mediators of transport in and out
of the nucleus, assembled from multiple copies of over 30 dif-
ferent nucleoporin (Nup) proteins (4). Transport ofmacromol-
ecules through the NPC is typically mediated by transport
receptors that bind/coat the cargo and interact with Nups to
negotiate the central channel of the NPC (reviewed in Ref. 5).
Binding of transport receptors to cargoes for nuclear import is
signal sequence-mediated (reviewed in Ref. 6). Import recep-
tors, such as importin/karyopherin , bind to classical basic
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nuclear localization signals (NLSs) (6). Some viral and cellular
factors known to be involved in transport interact with a variety
of transport receptors to facilitate recycling of proteins through
the NPC. Human immunodeficiency virus (HIV-1) Rev protein
interacts with multiple transport receptors, including importin
, transportin, importin 5, and importin 7 (7). Similarly, several
ribonucleoproteins like heterogeneous nuclear ribonucleopro-
tein (hnRNP)A1 are reimported into the nucleus through bind-
ing of transportin-1 to M9 transport sequences that occur in
many ribonucleoproteins. The transportin-1 uses interactions
with core NPCNups, including Nup62, to mediate the translo-
cation (8, 9). CRM1 is an export receptor for some RNA sub-
strates butmostly for proteins that bind to CRM1 through their
nuclear export signals (NESs) (10). CRM1 mediates the HIV-1
Rev shuttling via recognizing the Rev NES and binding to the
NPC (10, 11). TAP is the major cellular transport receptor for
export of mRNAs (12, 13). TAP-mediated transport is usually
facilitated by binding of REF/Aly to the cargo-receptor complex
(14); however, TAP directly binds some viral RNA sequences
like the constitutive transport element (15) of Mason-Pfizer
monkey virus.
Viruses tend to evolve mechanisms to control or inactivate
host cell nucleocytoplasmic transport through the NPCs. Sev-
eral viruses interfere with nuclear import or export pathways
via degradation and/or disruption of Nups and/or transport
receptors (16–21). For example, vesicular stomatitis virus
matrix protein inhibits bulk host cell mRNA export by forming
a complex with themRNA export factor RAE1 andNup98 (22),
whereas influenza virus NS1 protein targets the mRNA export
machinery by forming inhibitory complexes with the cellular
export receptors TAP/NXF1, p15/NXT, Rae1/Mrnp41, and
E1B-AP5 (23). The result is the same, but in each case a virus-
encoded protein associates with different NPC proteins to dis-
rupt host cell transport. In other cases, a core Nup is targeted
for degradation (e.g. poliovirus and rhinovirus inhibit nuclear
import of proteins presumably by degrading Nup62 and
Nup153) (17, 18). Nup62 is located at the core of the NPC (24)
and is directly targeted by several viruses (21, 25, 26), yet other
viruses provide their own transport receptors as in the case of
the human T-lymphotropic virus Tax protein that directly
interacts with Nup62 (27).
Herpes simplex virus (HSV) encodes ICP27, an immediate
early protein required for expression of early and late HSV-1
gene products, particularly through enhancing the expression
and export of intron-lacking herpes-encoded mRNAs (re-
viewed in Refs. 28 and 29). ICP27 is highly conserved among
herpesviruses, with at least 30% amino acid identity among the
herpesviridae (ORF57 in Kaposi’s sarcoma-associated herpes-
virus (KSHV), Mta/SM/EB2 in EBV, UL69 in human cytomeg-
alovirus). Both ICP27 and its KSHVandEBVhomologues func-
tion as export factors (30, 31) and are essential for virus
replication (32, 33). Viruses carrying mutations in ICP27 show
reduced levels of viral mRNAs, are defective in viral DNA rep-
lication (34–37), and fail to efficiently suppress cellular gene
expression (38).
ICP27 binds intronless HSV-1 mRNAs but not spliced viral
transcripts through its RGG domain (28, 29). The functions
reported for ICP27 involve multiple steps of mRNA synthesis
and processing, including transcription, splicing, nuclear
export (28, 29), and, recently, translation (39–41). Overall viral
RNA export is strongly reduced but not completely ablated
during infection with ICP27 mutant viruses. The remaining
RNA export during herpesvirus infection is probably due in
part to the function of adaptors SRp20 and 9G8 (42), which are
serine/arginine-rich proteins that control pre-mRNA splicing
and can bind directly to the export receptor TAP/NXF1
(reviewed in Ref. 43). Additionally, there appear to be both
ICP27-dependent and -independent pathways for different
herpesvirus transcripts because during viral infection the long
isoform of the UL24 transcript required ICP27 for its export,
whereas other viral transcripts, such as gC and UL42 tran-
scripts, did not (44). ICP27 effects on translation are also
mRNA-specific; ICP27 influences the expression of the essen-
tial HSV tegument protein and transactivator of immediate
early gene expression VP16 by inducing translation of VP16
mRNA, probably at the level of initiation (41). On the other
hand, polyribosomal analysis indicated that ICP27 is not
required for efficient translation of two other early HSV tran-
scripts (thymidine kinase and ICP8) (41).
A variety of interaction sites have been identified along the
ICP27 protein, including an N-terminal Leucine-rich repeat
(LRR) domain that binds the RNA polymerase II C-terminal
domain and Hsc70; a middle region that binds hnRNP K; and a
C-terminal domain that also binds RNA polymerase II C-ter-
minal domain, ICP8, protein kinaseCK2, and serine/arginine-
rich proteins (reviewed in Refs. 28 and 29). The N- and C-ter-
minal domains of ICP27 also fold intramolecularly to bind to
one another (45), and ICP27 interacts with itself to form mul-
timers via its C-terminal domain (46). Interestingly, the RNA
polymerase II binding domain overlaps with the TAP/NXF1-
binding site so that ICP27 and its associated RNAs can only be
exported after release from the polymerase.
ICP27 protein can shuttle in and out of the nucleus inde-
pendent of viral mRNA (47, 48), but ICP27 is observed primar-
ily in the nucleus at steady state (28, 29). ForHSV-1 viralmRNA
export, ICP27 principally operates through interactions with
the host export receptor TAP/NXF1 (48) and the transport
adaptor REF/Aly (47, 49). Leucine-rich NES-mediated export,
dependent on and independent of the CRM1 export receptor,
has also been reported (50); however, subsequent studies using
theCRM1 inhibitor leptomycin B have shown that CRM1 is not
absolutely required (47–49). Moreover, in Xenopus oocytes in
the absence of viral RNAs, export of ICP27 does not require
either the known TAP/NXF1 or CRM1 receptors (47). These
data argue for an alternative transport route for ICP27 nucleo-
cytoplasmic shuttling, possibly, like the human T-lymphotro-
pic virus Tax protein, through direct interaction with Nups
(27).
To investigate an alternative mechanism of ICP27 traffick-
ing, we tested if ICP27, like Tax, could interact with Nup62.
Both ICP27 and Nup62 co-immunoprecipitated with one
another in HSV-1-infected cells and interacted in vitro using
bacterially expressed tagged proteins. This interaction is RNA-
independent and is conserved because it was also observedwith
another herpesvirus homologue. We propose that these addi-
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tional binding sites at the NPC provide ICP27-bound viral
mRNA export complexes the advantage of facilitated export.
EXPERIMENTAL PROCEDURES
Cells, Infection, and Viruses—HeLa cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM; Invitrogen) with
10% fetal calf serum, 50 g/ml penicillin, and 50 g/ml strep-
tomycin at 37 °C in 5% CO2. BHK cells were grown in Glasgow
modified Eagle’s medium (Invitrogen) supplemented with 100
units/ml penicillin, 0.01% streptomycin, 10% newborn calf
serum, and 10% tryptose phosphate broth. HSV-1 wild type
(WT) strain was propagated in the BHK-21 cell line, and the
ICP27-complementing cell line, BHK-derived M49 (51), was
used for the growth and propagation of HSV-1 ICP27 viral
mutants. Complementing cell lines were cultured in DMEM
supplemented with 10% FCS and 5% tryptose phosphate broth.
Selection was achieved by maintaining cells in 800 g of
G418/ml and 750g of Zeocin/ml. Cellswere infectedwithWT
strain 17 or KOS1.1, for infected cell lysates with ICP27 viral
mutants. Strain vBSGFP27 (52) expressing GFP fused to ICP27
under its own promoter was used for imaging. Alternatively,
cells were infectedwith ICP27 null virus d27-1 (27), where the
ICP27 promoter and most of the gene coding sequence has
been deleted (37), or ICP27mutant strains carrying the N-ter-
minal deletionmutants dleu (53), d1-2 (54), d2-3 (55), d3-4 and
d4-5 (56), d5-6 (56), and d6-7 (55) or C-terminal point mutants
M15 and M16 (57). Virus was adsorbed onto cells for 1 h and
incubated at 37 °C. Viruses were used at multiplicities of infec-
tion (MOIs) given in the figure legends.
Plasmids—GST-ICP27 (58), GST-Nup62, GST-RaeI, and
GST-TAP (59) were kind gifts fromDrs. Steve A. Rice (Univer-
sity of Minnesota, Minneapolis, MN), Stuart A. Wilson (Uni-
versity of Sheffield), and Elisa Izaurralde (Max Plank Institute,
Tübingen, Germany), respectively, and GST-ORF57 (30) and
pCMV-10-ICP27 (60) have been described previously. His-
ICP27 encodes ICP27 fused to the N-terminal His tag from the
pET28 vector. mRFP-ICP27WTandM15 recombinant (ICP27
P465L/G466E) plasmids were constructed by moving the
EcoRI/BamHI insert of pEGFP-C1-ICP27 WT and M15 into
the mRFP-C1 vector (R. Tsien). ICP27 WT and deletion plas-
mid amino acids 10–512, 166–512, and 1–403 expressed from
pTriEx1.1-ICP27 have been described previously (47). The
reporter plasmid Rev48–116-GFP2-cNLS (NES-GFP2-cNLS)
was described (61). For construction of NES-GFP2-M9, the
HIV-1 Rev sequence containing the NES (amino acids 48–116)
was PCR-amplified and inserted into XhoI and SpeI sites of a
modified pEGFP-C1 vector coding for a GFP-GFP fusion pro-
tein with a C-terminal M9 sequence (the NLS of hnRNPA1)
(62).
Cell Lysis and Fractionation—For co-immunoprecipitation
experiments, total cellular protein lysates were obtained by
scraping cells into Nonidet P-40 lysis buffer (0.5% Nonidet
P-40, 150 mM NaCl, 50 mM Tris, pH 8.0, 2 mM EDTA, 10%
glycerol) with either the addition of ionic detergents (0.5%
sodium deoxycholate and 0.1% SDS) ormechanical shearing by
passing cells through a syringe, followed by treatment in a Bio-
ruptor (Diagenode), with the fresh addition of complete mini-
protease inhibitor mixture (Roche Applied Science) and com-
plete phosphoSTOP (Roche Applied Science). Shearing was
done by 10 passes through a 26-gauge needle, and sonication
was for 30–60 s cycles for 10 min in a Bioruptor (Diagenode),
and then lysates were left rotating at 4 °C for 30 min for solubi-
lization. Debris was pelleted by centrifugation at 13,000 g for
10–30min in a 4 °Cmicrocentrifuge. ForWestern blot analysis,
eluted proteins were mixed with 2 SDS sample buffer while
whole cell lysates were generated by scraping cells directly into
2 SDS sample buffer. In order to standardize the amount of
protein added to immunoprecipitations or pull-downs, cell
numbers were counted, and cell equivalents of total cell protein
content of soluble protein extracts were determined by Brad-
ford assay, or the various fractions were compared on SDS-
polyacrylamide gels and Western blotted to examine protein
expression.
Western Blot Analysis And Antibodies—Proteins were frac-
tionated by SDS-PAGE and transferred to nitrocellulose mem-
branes. Membranes were blocked with 5% milk powder in PBS
containing 0.1% Triton-X-100 (PBST) either overnight at 4 °C
or for 1 h. Membranes were incubated with primary antibodies
(Abs) in the same buffer for 1–2 h at room temperature or
overnight at 4 °C, washed, and incubated with anti-mouse IgG,
anti-rabbit IgG, or anti-goat IgG conjugated to horseradish per-
oxidase for 1 h with shaking. Following washing in PBST, pro-
teins on membranes were visualized either using ECL (GE
Healthcare) and exposed to Kodak X-Omat S film or analyzed
directly on a LI-COR Odyssey imager (LI-COR Biosciences)
using antibodies conjugated to fluorescent markers. Monoclo-
nal primary Abs used were against ICP27 (1119/1113, Virusys
Corp.; 1:2,000), GAPDH (catalog no. 4300, Ambion; 1:10,000),
His tag (Novagen), P53 Ab (DO-1, BD Pharmingen; 1:500),
PML Ab (5E10), Nup98 (2H10, AbCam; 1:1000), and TAP/
NXF1 (G-12) (sc-28377, SantaCruz Biotechnology, Inc.; 1:100).
Polyclonal Abs used were against GAPDH (E1C604-1; 1:500)
from Enogene and TAP/NXF1 (H-120, sc-25768; 1:1000) and
Nup62 (H-122, D-20, and N-19) from Santa Cruz Biotechnol-
ogy, Inc.
Microscopy—8 104 cells were grown on each 18 18-mm
coverslip overnight and then infected with virus or mock-in-
fected for the times stated. Coverslips were washed three times
with PBS and fixedwith 3.7% formaldehyde for 10min and then
permeabilized with 0.2% Triton X-100 for 5 min at room tem-
perature for fixation and finally washed three times with PBS.
Alternatively, cells were first pre-extracted with 1% Triton
X-100 in 25 mM Hepes, pH 7.4, 150 mM KOAc, 15 mM NaCl, 5
mMMgSO4 for images in Fig. 1 for 1min, washedwith PBS, and
then fixed with formaldehyde. Coverslips were blocked with
PBS containing 10–20% serum, 200 mM glycine, or 5% BSA for
1 h at room temperature and then incubated with primary Abs
diluted in 5% BSA or 1% calf serum in PBS for 1 h at room
temperature: ICP27 (1119/1113, 1:400, Virusys Corp.), mab414
(1:500; Covance), Nup62 (N-19; 1:50; Santa Cruz Biotechnol-
ogy), or TAP (1:200; gift from Elisa Izaurralde). Coverslips were
washed in PBS six times before incubation for 1 h with second-
ary Abs (Jackson Laboratories; donkey minimal cross-reactiv-
ity) diluted in 5% BSA or 1% (v/v) calf serum in PBS. After
washing in PBS six times, cells were incubated with 4,6-di-
amidino-2-phenylindole (DAPI; 1:2000) as a nuclear stain and
ICP27 Interaction with Nup62
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washed with PBS and coverslips were mounted with fluoro-
mount G (EM Sciences) mountingmedium. Images were taken
using a Nikon TE2000-U microscope with a 1.45 numerical
aperture, 100 objective, Sedat quad filter set, PIFOC z axis
focus drive (Physik Instruments), and CoolSnapHQ High
Speed Monochrome CCD camera (Photometrics) using
IPLab4.0 and Metamorph acquisition software. For Fig. 1,
image stacks (0.2-m steps) were deconvolved using Auto-
quantX, and all images were processed using Adobe Photo-
shop CS2.
Co-immunoprecipitation of Infected Cell Extracts—For
immunoprecipitations, protein A/G-Sepharose beads were
washed three times in Nonidet P-40 lysis buffer. Beads were
used to preclear cell lysates by incubation for 1 h at 4 °C with
rotation. When required mock- or virus-infected cells were
treated with 20 ng/ml LMB (Sigma) for 3 h prior to harvesting.
Where stated, cell lysates (500 g) were RNase I-treated (100
units) prior to use by incubation for 1 h at 37 °C. Cell extracts
weremixed with the anti-ICP27 AbsH1119 andH1113 or anti-
Nup62 Abs or negative control Abs for 2 h in binding buffer,
and protein A/G-Sepharose beads were added for another 2 h
or overnight. The precipitates were washed five times with cold
IPP150 (10mMTris-HCl, pH8, 150mMNaCl, 1%TritonX-100)
and eluted. Bound eluate was suspended in SDS-PAGE loading
buffer, heated for 5 min, and analyzed by SDS-PAGE. Western
blot analysis was performed usingAbs as described in the figure
legends.
Protein Expression in Escherichia coli—Expression of GST-
TAP (59) and GST-ORF57 (30) recombinant proteins has been
described. GST-ICP27 (58), GST-Nup62, GST-RaeI, and GST
alone recombinant proteins were expressed in E. coliBL21 cells
and purified on glutathione-Sepharose beads (GE Healthcare)
as described (60). Histidine-tagged ICP27 from pET-ICP27was
expressed in BL21 DE3 and purified using Talon resin (Clon-
tech) as described (47). Fusion proteins immobilized on beads
were pretreated with 0.2 unit of DNase I and 0.2 g of RNase I
per l for 30 min at 20 °C in 50 mM Tris-HCl, pH 8.0, 5 mM
MgCl2, 2.5 mM CaCl2, 100 mM NaCl, 5% glycerol, 1 mM DTT.
Beads were washed twice with 20mMTris-HCl, pH 7.5, 100mM
NaCl, 1 mM EDTA, 0.5%Nonidet P-40, 1 mMDTT and blocked
in the same buffer containing 10mg/ml BSA for 30 min at 4 °C.
After blocking, the beads were resuspended in binding buffer
containing 1 mg/ml BSA prior to use.
In Vitro Pull-down Assays—GST-Nup62 binding reactions
were carried out in 500 l of 10 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 1% Triton X-100, 10% glycerol buffer, using 5 g of GST
fusion protein bound to 20 l of glutathione-Sepharose 4B,
together with 100g of mock- or virus-infected cell lysates or 5
g of purified His-ICP27 protein. In some experiments, cell
lysates were treated with 5 g of RNase I prior to binding reac-
tions. Proteins were eluted from the resin using elution buffer
(50 mM Tris-HCl, pH 8.0, 20 mM glutathione) and analyzed by
SDS-PAGE.
Transient Transfection—For ectopic expression of ICP27,
HeLa cells on coverslips in 24-well dishes were transiently
transfected with 0.1 g/well pCMV-10-ICP27 (tr27) using
Fugene HD (Roche Applied Science). Medium was replaced
after 24 h. Cells were fixed 48 h after transfection and processed
for immunofluorescence microscopy.
Transport Assays—To analyze inhibition of nuclear import,
HeLa cells on coverslips in 24-well dishes were transiently
transfected with 0.125 g of NES-GFP2-cNLS or NES-GFP2-
M9, respectively, with or without 0.25 g of pCMV-10-ICP27
or pmRFP-C1 plasmid encoding WT ICP27 or mRFP-ICP27
M15 mutant, using Polyfect according to the instructions of
the manufacturer (Qiagen). For pTriEx-ICP27 WT and dele-
tion mutant expression, cells were transfected with 0.5 g of
plasmidDNAusing FugeneHD (Roche Applied Science). After
24 h, cells were fixed and processed for immunofluorescence
microscopy, using the anti-ICP27 Ab, or analyzed directly in
the case ofmRFP-tagged ICP27. Cells were analyzed by fluores-
cence microscopy with a Zeiss Axioskop2 microscope and
AxioVision software for those in Fig. 8 and a Nikon TE2000-U
microscope with a 1.45 numerical aperture 100 objective,
Sedat quad filter set, and CoolSnapHQ High Speed Mono-
chromeCCD camera (Photometrics) using IPLab4.0 andMeta-
morph acquisition software for those in Fig. 9. Pictures were
processed using Adobe Photoshop.
RESULTS
Subpopulation of ICP27 Associates at Nuclear Rim—ICP27
contributes to nuclear export of viral mRNAs and is known to
partly colocalize with the cellular mRNA export factor TAP at
early times after infection in the nucleus (48, 49). Thus, ICP27
co-localization with TAP and with the NPC itself was investi-
gated. In HSV-1-infected cells, ICP27 shows largely diffuse dis-
tribution throughout the nucleoplasm with some punctate
spots (63). The presence of strong signals from the large nucle-
oplasmic pool of ICP27 (see below) makes it difficult to distin-
guish if a separate pool of ICP27 is stably associated with the
NPC. Many nuclear envelope proteins, including Nups and
some transport receptors, resist a prefixation extraction with
detergent because of their interactions with the highly stable
structures of the nuclear lamin polymer and the NPC (64, 65).
Therefore, detergent extraction was used to determine if a sub-
population of ICP27 is stably associated with the NPC. Accord-
ingly, in Triton X-100-pre-extracted cells, some of the nucleo-
plasmic free ICP27 is washed away, leaving both punctate
accumulations in the nucleoplasmand a clear rim at the nuclear
periphery (Fig. 1A). This peripheral pool of ICP27 co-localizes
(yellow) at the rim with FxFG nucleoporins stained with
mab414, which recognizes several nucleoporins, including
Nup62, -98, -153, and -214, based on their unique O-linked
glycosylation. Co-localization is observed at 8 and 16 h postin-
fection but is not visible at 4 h postinfection (Fig. 1A).
TAP that also stably associates with theNPChas a significant
nucleoplasmic pool, like ICP27, that is mostly washed away
by the Triton prefixation extraction (data not shown). The
remaining TAP protein co-localizes with ICP27 at the
nuclear periphery (Fig. 1B). Notably, the distinct nucleoplas-
mic pool of ICP27 did not colocalize with TAP. This internal
ICP27 could be associated with viral replication centers,
indicating that there are at least three distinct subpopula-
tions of ICP27 during virus infection: nucleoplasmic extract-
able, nucleoplasmic resistant, and peripheral resistant. The
ICP27 Interaction with Nup62
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significant amount of ICP27 remaining associated in close
proximity of the NPC is consistent with expectations that
ICP27 actively shuttles and/or remains associated with viral
transcripts during transport.
ICP27 protein export in the absence of viral RNA requires
neither TAP nor CRM1 because the use of constitutive trans-
port element RNA or NES conjugates to block the TAP and
CRM1pathways, respectively, did not inhibit cytoplasmic accu-
mulation of ICP27 when reimport of ICP27 was inhibited (47).
Thus, an alternative route for export must exist. We postulated
that the ICP27 that resisted Triton extractionmight indicate an
alternative route involving direct interactions with core struc-
tural components of the NPC. In keeping with both poliovirus
andhumanT-lymphotropic virus proteins that interact directly
with Nup62, a core structural component of the NPC central
channel, we chose to test for possible interactions of ICP27with
Nup62. Some virus interactions with Nups result in degrada-
tion or redistribution of NPC components as happens during
poliovirus infection (16–21, 25, 26). Therefore, we first tested
Nup62 protein levels and localization in HSV-infected cells.
Protein levels were assayed by Western blotting of extracts
from cells that were mock-infected or infected with either WT
HSV-1 or HSV-1 carrying a deletion of the ICP27 gene (27).
During lytic infection with HSV-1 at MOI 10, ICP27 protein
starts to express as early as 2–3 h postinfection (hpi) (Fig. 2A,
first panel). The levels are readily detectable by 4 h (Fig. 2A,
middle panel) and peak between 8 and 16 h (not shown).
GAPDH staining confirmed similar protein loading. Because
cell lysis begins to occur several h after ICP27 levels have
peaked, ICP27 accumulation was also tested at 24 h at a lower
MOI. ICP27 was abundant still at 24 h postinfection, when
infected with HSV at an MOI of 1 (Fig. 2A, last panel). No
difference in Nup62 protein levels could be observed between
FIGURE 1. ICP27 associates at the nuclear periphery. HeLa cells infected
with HSV-1 vBSGFP27 (encodingWT ICP27 fused to GFP) were extractedwith
1% Triton X-100 prior to fixation at the postinfection times indicated. This
treatment removes protein that is not bound to resistant structures, such as
the nuclear envelope lamina, NPCs, and chromatin. A, after fixation, the
extracted cells were stained for mab414, which recognizes several nucleo-
porins based on their uniqueO-linked glycosylation. The extraction removed
enough of the diffuse nucleoplasmic pool of ICP27-GFP to be able to observe
an ICP27 rim at the nuclear envelope that co-localizes with the NPC. The
arrows point to the outer limit of the ICP27-GFP and the NPC staining. No
co-localization was observed at the 4 h postinfection time point. In contrast,
at 8 and 16 h post-transfection, significant co-localization can be observed.
One regionof the 16hpostinfection timepoint is enlarged in the lower panels.
B, the same experiment as in A was performed except that the transport
receptor TAP, which has previously been shown to interact with ICP27, was
stained for instead of the nucleoporins. Here small, boxed sections are
enlarged in some panels to more clearly observe the co-localization between
ICP27 and TAP, and two panels for each time point are shown. All images are
deconvolved from stacks with individual sections shown, and scale bars for
both A and B are 10 m.
FIGURE 2.Nup62 integrity during HSV-1 infection. A, Nup62 protein is sta-
ble in HSV-1-infected cells. Lysates were prepared from mock-infected HeLa
cells or HeLa cells infected with WT HSV-1 17 or an HSV-1 mutant with a
deletionof the ICP27gene (27). Cell lysates shownwerepreparedat 2, 4, and
24 h postinfection. MOIs used here are 10 for the 2 and 4 h time points and 1
for 24 h. Each lysate was reacted onWestern blots with Abs to ICP27, Nup62,
and GAPDH as a loading control. No obvious differences were observed in
Nup62 protein levels at any of the time points. B, Nup62 localization is also
similar in HSV-1-infected cells. HeLa cells either mock-infected or WT HSV-1
vBSGFP27-infectedwere fixeddirectly at 3 and18hpi and thenpermeabilized
and stained with Nup62 Abs. Viral ICP27 expression from its endogenous
promoter taggedwith GFP confirmed that individual cells were infectedwith
HSV-1. The distribution of Nup62 remained mostly peripheral in mock- and
virus-infected cells at early time points (3 hpi). At 18 hpi, some distinct cyto-
plasmic speckles of Nup62 were also seen, although nuclear rim localization
of Nup62 was still maintained. The vBSGFP27 virus used here has a slightly
slowergrowth rate comparedwithWTHSV-1 (52). Thearrowspoint to regions
with particular clustering of Nup62.
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mock, WT, and ICP27 null virus-infected cells at the times
tested (Fig. 2A), showing that HSV-1 does not down-regulate
Nup62 levels.
Next, we looked at the effect of HSV-1 infection on Nup62
localization by immunofluorescence. Because the aim was to
look at the total levels of intactNup62 in infected cells, we chose
to analyze Nup62 in directly fixed cells without Triton pre-
extraction. Nup62 (green) remains at the nuclear envelope in
non-extracted directly fixed cells, regardless of the presence of
ICP27 (red; in 3 and 18 hpi cells) (Fig. 2B). Similar to an earlier
report of changes in nuclear pore composition in some unin-
fected and infected cells (66), we also noted the presence of
some microclusters of Nup62 around the nuclear rim at 18 hpi
and a distinct speckled cytoplasmic staining in many cells
where nuclear integrity was still intact (late HSV-1 infection
compromises nuclear integrity), as observed by DAPI staining.
Thus, unlike during infection by several other viruses where
Nup62 is either degraded or heavily mislocalized, in HSV-in-
fected cells, Nup62 protein levels are not much different com-
pared with mock-infected cells but may cluster at the nuclear
periphery late in infection.
ICP27 Interaction with Nup62 Revealed by Co-immuno-
precipitation—To test for a physical association between ICP27
and Nup62, immunoprecipitation assays were conducted.
Nup62 protein was co-immunoprecipitated with ICP27 Abs
only in cells infected with WT virus and not in cells infected
with the ICP27 null virus or mock-infected cells (Fig. 3A). The
absence of ICP27 protein in the mock and ICP27 null virus
immunoprecipitated lysates was confirmed by staining the
immunoprecipitated fractionswith ICP27Abs. The presence of
Nup62 protein in all of the lysates used was confirmed in the
unbound panel, and the absence of an interaction with control
serum Abs (ctr) showed the specificity of the interaction with
ICP27 Abs.
In a reverse experiment, ICP27 protein was co-immunopre-
cipitatedwithNup62Abs. In agreementwith the above data, no
interaction was observed in mock-infected and ICP27 null
virus-infected cell lysates (Fig. 3B). In addition to the interac-
tion observed in WT virus-infected cell lysates, an interaction
was observed in cell lysates from M16 HSV-1-infected cells.
M16 is a mutant virus strain that has a point mutation in the
zinc finger motif at the C terminus of ICP27 (C488L). This
mutation has been shown to block interaction with TAP (48).
The interaction between ICP27 and Nup62 is not mediated by
viral RNA as has been shown for the TAP-NXF1 interaction
(48) because interactions were maintained upon treatment of
cell extracts with RNase I both during the lysis stage and during
immunoprecipitation reactions (Fig. 3B and supplemental Fig.
S1). Treatmentwith RNase Imay providemore sites for specific
protein-protein complex formation by reducing the amount of
transport receptors bound to RNAs. This could be the reason
why more ICP27 co-immunoprecipitated with the anti-Nup62
Ab in the presence of RNase I. Again, nonspecific serum Abs
served as a negative control, and Nup62 Abs immunoprecipi-
tated Nup62 protein in all lysates (Fig. 3B, lower panels). To
address the possibility that another Nup might mediate the
interaction between ICP27 and Nup62, several different Abs
against different epitopes of Nup62 were employed with the
same result (data not shown). Additionally, the possibility that
this in vivo interaction between ICP27 and Nup62 was specific
and does not co-immunoprecipitate irrelevant nonspecific pro-
teins was investigated by probing anti-Nup62 co-immunopre-
cipitations with antibodies to a nonspecific protein (supple-
mental Fig. S2)).
The above reactions were performed using human HeLa
cells. To ensure that potential differences in the character of
virus infection and cellular proteins do not contribute to the
observed ICP27-Nup62 interaction, we also tested for this
interaction using hamster BHK cells that are more permissive
for HSV-1 infection. A similar interaction between ICP27 and
Nup62was observed in BHK cells (Fig. 3C). Additionally, in this
FIGURE 3. Co-immunoprecipitation of ICP27 and Nup62. A, ICP27 Abs co-
immunoprecipitate Nup62. Left panels, Abs against ICP27 were incubated
with extracts frommock-infected,WTHSV-1-infected, and27-infectedHeLa
cell lysates. Immunoprecipitated complexes were analyzed by Western blot-
tingwithAbs againstNup62.Nup62 co-immunoprecipitatedwith ICP27 from
WTHSV-1-infected HeLa cell extracts but not frommock- or27-infected cell
extracts. Reaction of blots with Abs against ICP27 confirms that ICP27 was
only expressed in WT HSV-1-infected cells. Western blots of the unbound
material in reactions confirmed that Nup62 was present in all reactions. A
nonspecificmouse serumAbwasused as a negative control (ctr) that failed to
co-immunoprecipitate either ICP27 or Nup62 in WT HSV-1-infected lysates.
The band marked with an asterisk is the heavy chain of IgGs used for immu-
noprecipitations. B, the reverse immunoprecipitation reaction also indicates
an ICP27-Nup62 interaction. Nup62 Ab (H-122) co-immunoprecipitated
ICP27 from extracts of HeLa cells infected with either WT or a mutant HSV-1
strain (M16) carrying aC-terminal pointmutant (C488L) in ICP27. As expected,
no band corresponding to the molecular weight of ICP27 was observed co-
precipitating with Nup62 Abs from mock or 27 virus-infected cell lysates.
Again, a nonspecific control serum Ab failed to co-immunoprecipitate either
Nup62or ICP27, andNup62was immunoprecipitated fromall lysateswith the
Nup62 Abs. The bandmarkedwith an asterisk is the heavy chain of IgGs used
for immunoprecipitations. C, the interaction between HSV-1 ICP27 and the
host organism Nup62 is conserved across species because Nup62 Ab C-16
co-immunoprecipitated ICP27 from HSV-1-infected BHK cell extracts also.
100 g of lysate was used for the WT in lane 2, whereas only 50 g was used
for the WT in lane 4. Again, the control Ab failed to co-precipitate ICP27 from
WT-infected cell extracts. As a positive control for the experiment, ICP27 was
immunoprecipitatedusingAbs against ICP27 fromWTHSV-infected cells and
run on the same gel and blotted with anti-ICP27 Ab.
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experiment, different concentrations of WT-infected lysate
were used. The relative increase in the ICP27-Nup62 interac-
tion by varying input amounts of lysates with the same antibody
concentrations shows that the antibodies were not saturated in
these experiments and supports the specificity of the interac-
tion. As a positive control for ICP27 immunoprecipitation,
ICP27 was also immunoprecipitated fromWTHSV-1-infected
BHK cell lysates with Abs against ICP27 and run on the same
gel (Fig. 3C, far right lane).
ICP27-Nup62 Interaction Is Verified by Pull-downAssaywith
Bacterially Purified Components—To further confirm the
interaction of ICP27 with Nup62, we expressed and purified
GST and GST-Nup62 from bacteria and used these proteins to
pull down ICP27 from HSV-infected and mock-infected cell
extracts. Western blotting with anti-ICP27 Ab showed that
GST-Nup62 pulled down ICP27 from WT-infected cell
extracts (Fig. 4A) but not from ICP27 null-infected and mock-
infected cell extracts. The ICP27 interaction with Nup62 does
not require the presence of other viral proteins because GST-
Nup62 could also pull down ICP27 from uninfected HeLa cells
expressing ICP27 protein from a transfected plasmid (Fig. 4A,
tr27). GST failed to pull down ICP27 fromWTHSV-1-infected
cell extracts. Bacterially expressed proteins, including GST-
Nup62 and GST, used in these assays are shown in Fig. 5C.
GAPDH Ab confirmed that similar amounts of cell extracts
were added to all pull-downs (Fig. 4A, lower panel). The inter-
action with endogenous proteins was RNA-independent
because it occurred in RNase I-treated extracts (Fig. 4B and
supplemental Fig. S1). As a control, another GST fusion pro-
tein, Rae1 (see below), which is an mRNA export factor
involved in nucleocytoplasmic transport, was incubated with
extracts of cells infected with either WT HSV-1, 27 null, a
C-terminal ICP27 point mutant (P465L/G466E) HSV-1 strain
(M15), or mock-infected cell extracts (Fig. 4C). Proteins co-pu-
rifying on glutathione-Sepharose beadswere analyzed byWest-
ern blotting with an Ab against ICP27. Neither GST alone nor
GST-Rae1 pulled down ICP27 from any of the cell extracts,
which can be seen in the input cell extract lane (upper panel). A
doublet band of greater mobility in lanes 2–5, marked with an
asterisk, is a band from the GST-Rae1 bacterial protein prepa-
ration cross-reacting nonspecifically with anti-ICP27Ab. Input
cell extracts and GST alone served as a control for ICP27 in
pull-downs. GAPDH levels in the lysates served as a loading
control for these experiments (lower panel). Bacterially
expressed GST-Rae1 protein used in binding assays (Fig. 4C) is
shown on a Coomassie-stained gel (Fig. 4D).
FIGURE 4. Interaction of GST-Nup62 and ICP27 does not depend on RNA
or virus infection. A, Nup62 fused to GST and purified from bacteria in the
absence of any other mammalian proteins. Nup62-GST was incubated with
WT HSV-1-, 27-, and mock-infected cell extracts or with extracts from unin-
fected cells expressing ICP27 from a plasmid behind the CMV promoter.
Upper panel, Western blotting with Abs against ICP27. Lower panel, Western
blotting with GAPDH Abs as a loading control for lysates. Input and pull-
downswithGSTalonewereaddedon theends for controls.B, GST-Nup62was
incubated with WT HSV-1-infected lysates either with or without RNase I
treatment. Again, GST alone and inputwereused as controls.C, Rae1, another
transport receptor, does not pull down ICP27. Bacterially purified GST-Rae1
(67 kDa)was incubatedwith lysates fromWTHSV-1-,27 null virus-, amutant
HSV-1 strain (M15) carrying a C-terminal point mutant (P465L/G466E) in
ICP27-, ormock-infected cells.Upper panel, proteins co-purifying on glutathi-
one-Sepharose beads were analyzed by Western blotting with Ab against
ICP27. GST-Rae1 did not pull down ICP27 from any of the added cell extracts.
A doublet band running lower in lanes 2–5 and marked with an asterisk is a
band from the GST-Rae1 bacterial protein preparation cross-reacting non-
specifically with anti-ICP27 Ab. D, bacterially expressed GST-Rae1 protein
from the fusion protein preparation used in binding assays shown in Fig. 4C
was analyzed on a Coomassie-stained gel. The expected full-length protein
position is shownwith anasterisk, whereas thedouble asterisks indicate cleav-
age products of the full-length protein. E, GST-Rae1 and GST-TAP pull-down
known partner protein Nup98. Bacterially purified fusion protein GST-Rae1
(67 kDa) was incubated in the presence of RNase I with HSV-1 27 null virus-
infected or mock-infected cell lysates. Another fusion protein, GST-TAP, ear-
lier shown to interact with Nup98, and GST alone were also incubated with
HSV-1 WT virus-infected cell lysates. Proteins co-purifying on glutathione-
Sepharose beads shown as bound samples and unbound leftover samples
were analyzed by Western blotting with Ab against Nup98. Mock-infected
and 27 null virus-infected cell lysates were loaded as input. Bound samples
show that GST-Rae1 pulled down Nup98 from 27 null virus-infected or
mock-infected cell lysates, and GST-TAP also pulled down Nup98 from WT
virus-infected lysates. GST alone showed a weak band as background in
bound samples; however, the majority of Nup98 is not pulled down and is
present in unbound samples with GST alone, whereas not much is left as
unbound with mock.
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As a positive control for a Rae1 functional interaction, its
ability to bind a known partner protein, Nup98 (67), indepen-
dent of the presence of ICP27, was tested. Bacterially purified
GST-Rae1 or GST was incubated in the presence of RNase I
with extracts of cells infected with 27 null mutant HSV-1
strain or mock-infected. Proteins co-purifying on glutathione-
Sepharose beads were analyzed byWestern blotting with anAb
against Nup98. GST-Rae1 pulled down Nup98 from 27-in-
fected as well as mock-infected cell lysates (Fig. 4E, bound frac-
tion). A similar result was obtained for TAP that interacts with
Nup98 (68) using bacterially purified GST-TAP (Fig. 4E, bound
fraction). These data demonstrate that in our assay, bacterially
purified GST-RaeI and GST-TAP were able to bind partner
protein Nup98, and RaeI-Nup98 and TAP-Nup98 complexes
are formed in the mock-infected as well as virus-infected cells
in an RNA-independent manner. Thus, although ICP27 is
known to bind TAP receptor, it does not appear to compete
with TAP binding to Nup98. GST alone showed a weak band as
background in bound samples; however, themajority of Nup98
is not pulled down and is present in unbound sampleswithGST
alone, whereas no Nup98 is left as unbound with mock lysates
(Fig. 4E).
Nup62-ICP27 Interaction Is Direct—TAP has previously
been shown to bind to ICP27 at both ends (48). Therefore,
GST-TAP was used as a positive control for proper folding of
FIGURE 5. The Nup62-ICP27 interaction is direct, and TAP also binds
ICP27under similar conditions.A, GST-TAP pulls down ICP27 fromWTHSV-
1-infected cell extracts but not fromextracts of cells infectedwith a viral ICP27
C-terminal point mutant (M15; upper panel), whereas in the same binding
reactions, GST-TAP pulls down Nup62 from WT HSV-1-infected cell extracts
and from extracts of cells infected with a viral ICP27 C-terminal point mutant
(M15) or with ICP27 null mutant 27 virus and from mock-infected cell
extracts (upper panel). Bacterially expressed GST or GST-TAP was incubated
with extracts from WT-, 27-, or M15-infected HSV-1 strains. Proteins co-pu-
rifying on glutathione-Sepharose beads were analyzed by Western blot with
ICP27 or Nup62 Abs. B, ICP27 and TAP co-immunoprecipitate from HeLa cell
extracts in the presence of RNase I. Co-immunoprecipitation was carried out
by mixing anti-ICP27 antibodies 1113 and 1119 with HSV-1 WT and ICP27
mutantM15 and null27 viruses andmock-infected HeLa cell extracts. Com-
plexes formed were separated by SDS-PAGE followed by Western blotting
with anti-TAP and ICP27 Abs. ICP27 co-precipitated TAP. Upper panel, co-
immunoprecipitationof TAP inWT-infectedHeLa cell extracts in thepresence
of RNase I by ICP27 but no co-immunoprecipitation with M15-, 27-, and
mock-infected cells. Input, mock-infectedHeLa cell extract. The lower band in
the input lane couldbedue to another cellular protein cross-reactingwith this
TAP Ab, but the correct size upper band specific to TAP is clearly seen. The
bandmarkedwith an asterisk is the heavy chain of IgGs used for immunopre-
cipitations. ICP27 immunoprecipitated itself. The lower panel shows immuno-
precipitation of ICP27 in WT- and M15-infected HeLa cell extracts in the
presence of RNase I by its Ab but no immunoprecipitation in27- andmock-
infected cell extracts. C, the purity of various fusion proteins used for in vitro
binding assays. Coomassie-stained 10% SDS-PAGE of bacterially expressed
proteins used in Figs. 4–7. The single asterisk indicates the molecular weight
of the expected protein product, whereas the double asterisks indicate cleav-
age products of the full-length protein. Prestained molecular weight protein
markers are loaded on the leftmost lanewithGST alone.D, bacterially purified
His-tagged ICP27was incubatedwith bacterially purified GST-Nup62, GST, or
GST-TAP proteins on glutathione-Sepharose beads. Protein complexes
formedwere eluted by reduced glutathione and separated by SDS-PAGE and
Western blotted with anti-His Ab. His-ICP27 interacted with GST-Nup62 and
GST-TAP but not GST alone. E, an unrelated nonspecific His-tagged fusion
protein (His-mRFP) does not interact with GST-tagged TAP or Nup62 fusion
proteins. Bacterially purified His-tagged mRFP fusion protein was incubated
with bacterially purified GST-TAP, GST-Nup62, or GST alone on glutathione-
Sepharose beads in the presence of RNase I. Protein complexes eluted by
reduced glutathione and separated by SDS-PAGE are shownon aCoomassie-
stained gel. His-mRFP (corresponding to the band in input) does not interact
withGST-TAP, GST-Nup62, andGST alone in bound samples run ongel (upper
panel), but His-mRFP is present in all unbound pull-down samples run on
Coomassie (lower panel). Purified His-mRFP alone protein added to the pull-
down reactions was loaded as input. Molecular weight protein marker sizes
are given in kDa on the left.
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the bacterially purified tagged ICP27 protein (see below). First,
GST-TAP was able to pull down ICP27 from WT HSV-1-in-
fected cell extracts (Fig. 5A, upper panel) but not from the
ICP27 null virus-infected extracts (27) or from extracts of
cells infected with an HSV-1 mutant strain carrying a C-termi-
nal point mutation in ICP27 at the known site of interaction
with TAP (M15). As a negative control, GST failed to pull down
ICP27 from WT HSV-1-infected cell extracts. TAP interacts
with Nup62 (68), so, as a specificity control for the binding
reactions shown above, GST-TAP was tested to determine if it
was able to interact with Nup62 under the same conditions.
Western blot with anti-Nup62 Ab showed that GST-TAP
pulled down Nup62 fromWTHSV-1-infected cell lysates (Fig.
5A, lower panel) as well as from the ICP27 null virus-infected
lysates and from lysates of cells infected with an HSV-1 virus
carrying aC-terminal pointmutation in ICP27 (M15) andmock
cells. This demonstrates that TAP-ICP27 (Fig. 5A, upper panel)
and Nup62-ICP27 complex (Fig. 4, A and B) formed in theWT
virus-infected cells, whereas the TAP-Nup62 complex formed
in both infected (WT, null, and M15 mutant) and mock-in-
fected cells (Fig. 5A, lower panel). To test the RNA requirement
for the above binding, we performed anti-ICP27 co-immuno-
precipitations in the presence of RNase I fromvariousHeLa cell
lysates. Western blotting with anti-TAP antibodies showed co-
immunoprecipitation of TAP inWT-infected HeLa cell lysates
in the presence of RNase I by ICP27 but no co-immunoprecipi-
tation with M15-, 27-, and mock-infected lysates (Fig. 5B,
upper panel). Mock-infected RNase-treated HeLa cell extracts
were used as an input positive control for TAP. ICP27 immu-
noprecipitated itself inWT- andM15-infectedHeLa cell lysates
in the presence of RNase I, but no co-immunoprecipitationwas
observed in 27 and mock-infected cell lysates (Fig. 5B, lower
panel).
To test if ICP27 interacts with Nup62 directly, independent
of any other bridging factor,His-tagged ICP27 andGST-Nup62
were expressed and purified from E. coli for use in an in vitro
pull-down assay. Various proteins used in the in vitro binding
assays are shown in Fig. 5C.Western blottingwas performed on
bound samples using anti-His Ab to identify the bound full-
length His-tagged ICP27 protein. Both the purified GST-TAP
andGST-Nup62 were able to pull down the purifiedHis-ICP27
in the absence of other viral or mammalian cell proteins (Fig.
5D), confirming that GST-p62 interacts directly in vitro with
ICP27. The ratio of bound bacterially purified protein com-
pared with the input consistently appeared to be less than the
ratio when ICP27 was bound frommammalian cell lysates (Fig.
4, A and B), suggesting that some posttranslational modifica-
tions may contribute additively to this complex formation.
Again, as a negative control, GST alone failed to pull down
His-ICP27. The bacterially purified proteins in our preparation
contain cleavage products of the full-length fusion proteins
because it is quite difficult to express and purify non-cleaved
full-length proteins from ICP27 family herpes viral proteins,
although the lack of full purification means that there is a pos-
sibility that other bacterial proteins in the ICP27 fusion protein
preparation mediate any interaction. However, we have
included a number of internal negative and positive controls in
binding assays that argue against this possibility. Moreover, a
positive ICP27-Nup62 co-immunoprecipitation occurring
with high salt titration (washwith 500mMNaCl) provides addi-
tional evidence of specificity of binding (data not shown).
Additionally, for the direct in vitro pull-down assay, the spec-
ificity was further confirmed using an irrelevant, nonspecific
His-tagged fusion protein (His-mRFP) expressed in bacteria
and purified to the same extent as the ICP27 fusion proteins.
The His-mRFP fusion protein, present in all binding reactions
(Fig. 5E, upper panel (band corresponding to the input lane)
and lower panel (all lanes)), did not interact with GST-TAP,
GST-Nup62, or GST alone in pull-down assays. Hence, ICP27
binding to GST-TAP and GST-Nup62 was probably not due to
poor protein preparation or other bacterial proteins mediating
the binding.
Nup62-ICP27 Interaction Is Conserved across Herpesviridae—
GST-fusion proteins were also purified for ICP27 and its KSHV
homologue ORF57. Both were able to pull down Nup62 from
HeLa cell extracts (Fig. 6A). Moreover, the amount of Nup62
associating with GST-ICP27 and GST-ORF57 from the HeLa
extracts was very similar (Fig. 6A). No interaction occurred
between Nup62 and GST, confirming the specificity of the
interaction (Fig. 6A, last lane). The lower band marked with an
asterisk in lane 2 is possibly a band from theGST-ICP27 protein
preparation cross-reacting nonspecifically with Nup62 Abs. To
further confirm that nonspecific irrelevant proteins did not also
bind to ICP27 orORF57 fusion proteins, pulled down reactions
were blottedwith anti-GAPDHAb. This showedGAPDHpres-
ent only in the input and not in the pulled down samples (Fig.
6B). GST-ICP27, GST-ORF57, and GST alone present on the
beads used in the binding reactions are shown in Fig. 6C.
Mapping of Binding of Nup62 on ICP27—To map the inter-
acting regions of ICP27 with Nup62, we used purified GST-
Nup62 and GST alone to pull down ICP27 from cell lysates
infected withWT virus or a panel of ICP27mutant viruses. The
mutants (Fig. 7A) have been used previously for other mapping
studies to define the functional domains of ICP27 (37, 53–56).
In particular, a series of deletion viruses covering the whole
N-terminal region was tested, including deletions in the NES,
NLS, and RGG sequences. Additionally, ICP27 C-terminal
point mutant viruses M15 (P465L/G466E) and M16 (C488L)
were tested (57); the positions of these mutations are shown
with double and single asterisks in the ICP27 schematic in Fig.
7A. GST-Nup62 pulled down all N-terminal ICP27 deletion
mutants except for dleu (aa 6–19) that removed the NES (Fig.
7B). Despite significant levels of expression of the ICP27 pro-
tein from dleumutant virus as seen in unbound lysate fractions
(Fig. 7B, lower panels), no ICP27 was pulled down with GST-
Nup62. In contrast, other ICP27 N-terminal mutant proteins
like those from d1-2 and d3-4 viruses bound to GST-Nup62, as
did ICP27 deletions up to d6-7, confirming that apart from the
extreme N terminus, most of the N-terminal region is not
required. However, the N-terminal leucine-rich region may
contribute to the interaction of ICP27 with Nup62. Interest-
ingly, neither C-terminal mutant of ICP27 (M15 or M16) was
pulled down by the GST-Nup62. It is known that expression of
ICP27 protein from these C-terminal mutant viruses (M15 and
M16) is reduced as compared with that of the ICP27 protein
from theWT virus (48); we see this also in the unbound lysates
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(Fig. 7B, lower panels). Nonetheless, the absence of an interac-
tion with viral M15 and M16 C-terminal mutants was not due
to our inability to analyze this interaction due to the reduced
expression levels of ICP27 mutant protein. When the amount
of M15 and M16 input lysates added to the GST-Nup62 pull-
down reactions was increased, the C-terminal mutants still
failed to pull down detectable levels of ICP27 (data not shown).
Lack of interaction of GST-Nup62 with mock- and ICP27 null
virus-infected lysates (Fig. 7B) and the GST control with WT
(far right lane) indicated the specificity of the binding reactions.
Thus, the C terminus and a small region of the N-terminal
segment appear to be important for ICP27 interactions with
Nup62.
ICP27 Blocks bothM9 andNLS-mediatedNucleocytoplasmic
Transport Pathways—The ability of ICP27 to interact directly
with a core NPC protein in an RNA-independent manner sug-
gested that ICP27 might have either a more direct role in its
own shuttling/recycling or additional as yet undefined effects
on other nucleocytoplasmic transport pathways during the
course of HSV-1 infection. To test for an effect on other trans-
port pathways, ICP27 was expressed together with cargo
reporters for different transport pathways. Both reporters had
two GFP moieties in tandem to bring them above the free dif-
fusion limit for NPC transport and were able to shuttle. On the
N terminus of both was the HIV Rev NES, which is exported in
a CRM1-dependent manner, but this was countered by an M9
signal or strongNLS at the C terminus. The first reporter, NES-
GFP2-M9, carried the M9 sequence from hnRNP A1 (69) that
utilizes transportin as an import receptor and is independent of
importin/karyopherin  and  (70). At steady state, this
reporter accumulates in the nucleoplasm inHeLa cells (Fig. 8A,
middle row of the central panel), apparently because import is
dominant over export.Whenplasmid (pCMV-ICP27)-encoded
ICP27 was co-expressed with the M9 reporter (Fig. 8A, lower
right panel), the predominant nuclear localization of the M9
reporter construct was largely abolished (Fig. 8A, middle right
panel). Now the reporter was equally distributed between the
two compartments, demonstrating an inhibition of the trans-
portin pathway by ICP27. ICP27 is a shuttling protein; at steady
state, however, it mostly localizes to the nucleus with some
cytoplasmic localization. The amount of ICP27 cytoplasmic
localization depends on the cell type, the levels of expression,
and the time postinfection. At late times postinfection,
where there are elevated levels of both ICP27 and tran-
scribed viral mRNAs, ICP27 localizes also to the cytoplasm,
possibly shuttling faster with its substrate mRNAs (47).
When ICP27 alone was expressed ectopically from a plasmid
(pCMV-ICP27) without the reporter and in the absence of
infection, the ICP27 accumulated in both the nucleus and
cytoplasm of the cells (Fig. 8A, lower left panel). The partial
cytoplasmic localization of ICP27 expressed from plasmid
DNA could result from the lack of viral RNA substrates, but
FIGURE 6.Nup62 interacts with ORF57, an ICP27 homologue from KSHV.
A, mock-infected HeLa extracts were incubated with either GST-ICP27, GST-
ORF57 (a homologue of ICP27 from KSHV), or GST alone. Complexes isolated
on glutathione-Sepharose beads were eluted after washing, separated on
10%SDS-PAGE, transferred to nitrocellulosemembranes, and incubatedwith
Abs against Nup62. Both ICP27 homologs pulled down Nup62. 33% of the
HeLa cell extracts used for binding were loaded as input, and one-half of the
pull-down reaction samples eluted from the beads were loaded on the gel.
The lower bandmarkedwith anasterisk in lane 2 is a band from theGST-ICP27
protein preparation cross-reacting nonspecifically with Nup62 Ab. B, control
proteinGAPDHdidnotbind to ICP27andORF57 fusionproteins. Pulleddown
reactions of ICP27, ORF57 fusion proteins, and GST alone with HeLa lysates
were blotted with anti-GAPDH Ab, and this showed GAPDH present only in
the input and not pulled down in bound samples. C, Coomassie-stained 10%
SDS-PAGE of bacterially expressed proteins GST-ICP27, GST-ORF57, and GST
alone present on the beads used in the binding reactions here and in Fig. 5A.
The single asterisk indicates the molecular weight of the expected protein
product, whereas the double asterisks indicate cleavage products of the full-
length protein.
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also higher expression levels of ICP27 may push some into
the cytoplasm. Upon co-expression with reporter cargo
receptors, ICP27 localization also appeared to be slightly
more cytoplasmic (Fig. 8A, lower right panel) possibly as a
result of competition for or saturation of common factors at
nuclear pores. The NES-GFP2-M9 reporter construct also
accumulated in the cytoplasm when co-transfected with
another plasmid (pTriEx-ICP27) encoding full-length ICP27
WT protein (Fig. 8B, middle panel), further supporting an
inhibition of the transportin pathway by ICP27.
To determine if ICP27 inhibition of transport is unique to the
transportin-dependent pathway or if ICP27 can inhibit multi-
ple pathways, a second reporter (NES-GFP2-cNLS), represent-
ing the classical importin/karyopherin /-dependent import,
was assayed. This reporter carried the SV40 classical basic NLS.
It is able to shuttle because its export out of the nucleus is
mediated by the HIV Rev NES in a CRM1-dependent manner.
At steady state, it localized almost exclusively in the nucleus,
apparently because its import is dominant over export (Fig. 8C,
left middle panel). When ICP27 was co-expressed with the
NES-GFP2-cNLS reporter (Fig. 8C, right panels), the reporter
was observed predominantly in the cytoplasm (Fig. 8C, right
middle panel) along with ICP27 (Fig. 8C, right lower panel).
Thus, ICP27 also inhibits the importin/karyopherin transport
pathway. Images shown (Fig. 8) are representative of at least
three experiments performed. A similar phenotype of reporter
localization distribution also to the cytoplasm was observed in
more than 90% of dual co-transfected cells. Very few (10%)
FIGURE 7.Mapping of Nup62 interaction sites on ICP27. A, schematic of ICP27, N-terminal deletion mutants, and C-terminal point mutants. The NES, NLS,
and the RGGviral RNAbinding site aremarked alongwith the three hnRNPKhomology domains (KH1 to -3). In the third conserved domain are the Smand zinc
finger regions that are disrupted by the M15 (P465L/G466E) and M16 point mutations (C488L) (57), respectively, and are represented with double and single
asterisks, respectively. B, GST-Nup62 was incubated with lysates from cells infected with herpesviruses carrying the listed ICP27mutations. The material that
bound to GST-Nup62 and eluted from glutathione-Sepharose beads is shown in the upper panels, whereas the unboundmaterial is shown in the lower panels
to confirm that the viral proteinswere expressed. All co-precipitated proteins are visualizedwith the ICP27monoclonal Abs, either 1113 or 1119 because 1113
Ab is raised against a region of ICP27 that is missing inmutant d3–4 and 1119 Ab is raised against a region that is missing in dleumutant. Standard GST alone
and input controls were employed.
FIGURE8. ICP27blocksbothNLSandM9-mediatednucleocytoplasmic transportpathways.A, left panels, ICP27 accumulates both in thenucleoplasmand
the cytoplasm of uninfected cells transfected with a WT ICP27-encoding plasmid. Middle panels, HeLa cells were transfected with a plasmid encoding just a
NES-GFP2-M9 reporter that contains the CRM1-dependent NES of HIV-1 Rev and the transportin-dependent M9-NLS of hnRNPA1. This construct accumulates
in the nucleoplasm when transfected alone but in the cytoplasm when co-transfected with ICP27 (right panels). B, NES-GFP2-M9 reporter construct when
co-transfectedwith ICP27 encoded frompTriEx-ICP27WTplasmid also accumulates predominantly in the cytoplasm. C, similarly, a different reporter was used
(NES-GFP2-cNLS) that contains the CRM1-dependent REVNES and the importin/karyopherin/-dependent (classical) NLS. It accumulates in the nucleoplasm
when expressed alone (left panels) and in the cytoplasm when both ICP27 and NES-GFP2-cNLS are co-transfected (right panels). Scale bar, 10 M.
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dual transfected cells showed only nuclear localization of the
reporters.
To test if this ability of ICP27 to inhibit multiple host cell
nucleo-cytoplasmic transport pathways was likely to require its
interaction with Nup62, the ICP27 C-terminal mutant M15
that did not interact with Nup62 (Fig. 7B) was expressed from a
plasmid independently of viral infection (Fig. 9, A and second
panels of B and C). The plasmid construct was used because
M15 protein levels were lower thanWT ICP27 in cells infected
with mutant viruses. To determine if this approach increased
M15 levels, lysates from cells expressing WT ICP27 or the
mutant were analyzed by Western blotting (supplemental Fig.
S3). Indeed, this yielded similar protein levels for comparison,
and at similar exposure times, fluorescence intensity of proteins
expressed frombothwas similar too (data not shown). For these
experiments, both the M9 reporter construct that utilizes
transportin as an import receptor (NES-GFP2-M9) and the
cNLS reporter construct that is dependent on the importin/
karyopherin/ pathway (NES-GFP2-cNLS)were used. Unlike
theWT ICP27 that redistributed the reporter to the cytoplasm,
theM15mutant yielded predominantly nuclear staining for the
reporters (Fig. 9, B andC, second panels). This suggests that the
interaction of Nup62 with the C-terminal region of ICP27 is
required for ICP27 inhibition of host cell transport.
Other ICP27mutants (Fig. 9A) were also examined for their
effects on the NES-GFP2-M9 (Fig. 9B) or the NES-GFP2-cNLS
(Fig. 9C) reporters using plasmid-encoded ICP27 mutant pro-
teins. Previously, in mutant virus infections, most of the ICP27
proteins carrying N-terminal deletions were able to interact
with Nup62, whereas C-terminal point mutants were not (Fig.
7B). When co-expressed from exogenously introduced plas-
mids, these ICP27 mutants had variable effects on the localiza-
tion of the reporter proteins. NES-GFP2-M9 and NES-GFP2-
cNLS reporters localized also to the cytoplasm in 70 and 80% of
cells when co-transfected with the ICP27 N-terminal deletion
mutants 10–512 and 166–512, respectively (Fig. 9, B and C,
middle panels). The N-terminal mutant 10–512, which deletes
only part (aa 6–9) of ICP27 NES (aa 6–19) in 70% of cells
showed a phenotype similar to full-length WT ICP27 protein
(first panels). In some cells (20% of cells), nuclear retention of
the reporter protein was observed, whereas for the ICP27
mutant 166–512, altered cytoplasmic redistribution was seen
in more cells (80%) compared with nuclear retention (10%).
This is in agreement with most of the ICP27 proteins carrying
FIGURE9.Effect of ICP27mutants onbothNLSandM9-mediatednucleocytoplasmic transport pathways.A, schematic ofmRFP-M15 ICP27pointmutant
fusion protein, N-terminal, and C-terminal deletion mutants. The Sm region is disrupted by the M15 (P465L/G466E) point mutations (57), with the position of
themutation shownwith double asterisks. N-terminal (aa 10–512, 166–512) and C-terminal (aa 1–403) deletionmutants are expressed frompTriEx-1.1 vector.
B, the NES-GFP2-M9 reporter construct accumulates in both the cytoplasm and nucleoplasmwhen co-transfectedwith a plasmid encodingWT ICP27 fused to
mRFP (mRFP-ICP27WT) or several N-terminal deletion mutants (pTriEx-ICP27, aa 10–512, 166–512), but with the M15 ICP27 C-terminal point mutant and the
C-terminal deletionmutant (pTriEx-ICP27, aa 1–403), the reporter accumulated in the nucleoplasm, indicating that an intact functional C terminus is required.
C, the NES-GFP2-cNLS reporter construct accumulated in the cytoplasm when co-transfected with ICP27 encoded from mRFP-ICP27 WT and N-terminal
deletion mutants, but when cells were instead co-transfected with the M15 ICP27 point mutant or the C-terminal (aa 1–403) deletion mutant, the reporter
accumulated in the nucleoplasm.
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N-terminal deletions able to interact with Nup62 except for
dleu, where the NES region alone is missing. Additionally, it
indicates the existence of alternative routes of shuttling for
these N-terminal mutants. Loss of interaction in dleu may pos-
sibly be due to unavailability of interacting sites as a result of
altered folding of the mutant protein, whereas the C-terminal
deletion mutant 1–403 and the M15 C-terminal ICP27 point
mutant that do not bind to Nup62 did not alter the distribution
of either of the reporters significantly. The staining remained
mostly in the nucleus in dual co-expressing cells (Fig. 9,B andC,
last middle panels). Representative images for this are shown in
Fig. 9,B andC. These results further strengthen the importance
of the C-terminal region and ICP27-Nup62 interaction for
ICP27 activity.
DISCUSSION
Herpesviruses are nuclear replicating DNA viruses that need
to transport mRNAs and proteins across the nuclear envelope
because of the compartmentalization of the host cellular tran-
scription and translation machinery upon which the virus
depends. Viruses use a variety of mechanisms to selectively
block hostmRNAexport. Understanding themolecular basis of
these mechanisms has important implications for developing
novel antiviral treatments. Previous studies on ICP27 interac-
tions with the cellular transport machinery have mostly exam-
ined the roles for ICP27-mediated viral RNA export utilizing
the cellular mRNA export receptor TAP that allows the intron-
less herpesvirus mRNAs to be preferentially transported. To
date, the mechanism for shuttling of viral RNA-independent
free ICP27 has remained inconclusive (47) because ICP27
export isNES region-mediated but not dependent on the recep-
tor CRM1, which is the major NES-recognizing cellular export
receptor. Additionally, in virus-infected mammalian cells
where ICP27 substrate viral RNAs are also present, ICP27
mRNA export is shown to be TAP-dependent using siRNAs to
TAP (47–49). However, export of free ICP27 not bound to viral
RNA is TAP-independent because the constitutive transport
element did not inhibit ICP27 export when tested by nuclear
microinjection in Xenopus oocytes (47). Binding of ICP27 to
specific viral RNA substrates could alter either ICP27 confor-
mation or the ICP27-RNA-partner protein complex configura-
tion. The interaction between ICP27 and Nup62 demonstrated
here is the first example of herpesviruses able to directly utilize
NPC core components andmay provide an explanation for dis-
crepancies in attempts to explain ICP27 shuttling. This inter-
action appears to be functionally relevant because WT ICP27,
but not C-terminal mutants that failed to interact with Nup62,
can inhibit transport of substrates of some of the cellular trans-
port receptors tested. Such an interaction would provide an
advantage to the virus because ICP27 may compete with and
block transport of host substrates.
TAP- and CRM1-mediated export pathways converge at the
NPC as CRM1 competes strongly with TAP for binding to
Nup214 and prevents export by the TAP transport domain
(71). Competition for binding to a Nup at the nuclear pore is a
possible explanation for the inhibition by ICP27 of transport of
reporter substrates observed here. As an example of import
pathways converging at the NPC, transportin inhibited
karyopherin /1-mediated import of a classical NLS-contain-
ing substrate, and, vice versa, karyopherin 1 inhibited trans-
portin-mediated import of the hnRNPA1-based substrate, sug-
gesting that the two import pathways merge at the level of
docking of 1 and transportin to Nups (8, 9). Thus, ICP27 may
shuttle by utilizing different components of the host transport
machinery, possibly varying pathways at different stages of the
viral replication cycle.
Several cellular and viral proteins continuously shuttle
between nuclear and cytoplasmic compartments, including
hnRNPs (72, 73), U1 small nuclear ribonucleoprotein-specific
protein U1A (74), influenza virus NS1 (75), andHIV-1 Rev pro-
tein (76). Although the physiological significance of nuclear
shuttling is not known in all cases, someRNA-binding shuttling
proteins have roles inmRNAexport. hnRNPA1 associates with
RNA polymerase II-derived transcripts in both the nucleus and
cytoplasm and is thought to directly mediate their transport
(73). ICP27 is able to efficiently shuttle in the presence ofCRM1
inhibitor LMB because the addition of LMB did not inhibit the
export of ICP27 (77). These recent data and several earlier
reports (47–49) show that ICP27 does not require CRM1 for its
nuclear export. ICP27 interacts with Aly/REF, which recruits
the TAP cellular mRNA export pathway (47, 49), and TAP/
NXF1 is required for export (48). However, recent data show
that Aly/REF is dispensable for ICP27-mediated export of HSV
mRNA (78). Moreover, Aly/REF knockdown has little effect on
viral RNA export (42). HIV-1 Rev protein binds to Rev response
elements in viralmRNAs tomediate their export and also inter-
acts with core Nups via CRM1 (79). HSV-1 ICP27 is known to
bind intronless RNAs and function in their export (reviewed in
Refs. 28 and 29), and we postulate that, like HIV Rev, ICP27
could use core Nups in this transport process.
Using a heterokaryon assay able to test the shuttling activity
of proteins, ICP27WTwas able to shuttle efficiently (80). Shut-
tling of some of the ICP27mutants has also been tested.Mutant
d1–2 (which deletes aa 12–63, including part of the NES, aa
6–19) showed reduced shuttling (80). The ICP27 M15 C-ter-
minal point mutant completely abrogates shuttling activity
(80). M15 virus is totally replication-defective (57), whereas
deletion of ICP27 NES (aa 6–19) in the dleu mutant weakened
but did not abrogate shuttling, and dleu is replication-deficient
(77).
That mutations in amino acids 6–11 at the N terminus and
mutations at the C terminus of ICP27 both affect the interac-
tion in vitro with bacterially purified Nup62 suggests that both
regions of ICP27may act together forNup62binding.However,
N-terminal mutant 10–512, which deletes part (aa 6–9) of the
ICP27 NES (aa 6–19) when used in the transport assay, in 70%
of cells showed a phenotype similar to full-length WT protein.
In fewer cells, nuclear retention of the reporter protein was also
observed. Our observations are similar to those reported earlier
that mutant d1–2 (which deletes aa 12–63, including part of
NES aa 6–19) showed reduced shuttling (80), and in the dleu
mutant, deletion of NES (aa 6–19) of ICP27 weakened but did
not abrogate shuttling. Mutant ICP27 dleu virus is replication-
deficient (77) but not replication-defective. Hence, for these
N-terminal mutants, alternative routes for nuclear egress
appear to exist when other regions of the protein, especially the
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C terminus, are intact. Our observations are not quantitative in
nature but help us to understand the role(s) played by various
segments of ICP27. From the ICP27-Nup62 interaction even in
the presence of LMB (supplemental Fig. S2) and from transport
assays utilizing various N- and C-terminal ICP27 plasmid
mutations, it becomes clear that, although the N-terminal
region of ICP27 affects its ability to bind Nup62 in vitro, func-
tionally it appears to be the C terminus of ICP27 that acts as the
major region of importance for shuttling of viral protein. These
data revealed thatmutants that reduce protein-protein interac-
tions with Nup62 at the C terminus alter and dramatically
decrease the ability of ICP27 to shuttle and also inhibit multiple
host cell nucleo-cytoplasmic transport pathways. The ICP27
M15 mutant protein appears to be able to enter the nucleus
after synthesis in the cytoplasm via alternative routes; however,
its ability to export out of the nucleus seems to be defective.
Loss of Nup62 interaction correlates with the inability of M15
to re-export and shuttle continuously, and it appears that as a
result of the loss of this crucial function, M15 is replication-
defective (57).With regard to cellular and viral mRNAprocess-
ing, HeLa cells infected with M15 mutant virus failed to accu-
mulate cellular unspliced-globin pre-mRNA, andmutation in
theM15 virus greatly increased the length and heterogeneity of
the poly(A) tail of spliced -globin mRNA (81). Additionally,
ICP0 is one of the few intron-containing viral genes, and it
yielded no detectable intron 1-containing transcripts in M15
infections (81). M15 protein has been reported to have an
exclusively nuclear distribution (80), and in contrast to theWT
ICP27 protein, the M15 mutant protein was absent from the
polyribosome fractions (40). It remains possible, however, that
the M15 mutation might affect activities of ICP27 other than
NPC interaction.
Involvement of the CRM1-independent, extreme N termi-
nus leucine-rich NES region of ICP27 in its interaction with
Nup62may simply be due to a structural requirement of ICP27
in forming a viable conformation in vivo. Recent data indicate
that ICP27 can acquire an intramolecular head-to-tail confor-
mation (45) that could provide such a binding site involving
both ends of the ICP27 molecule. The intramolecular head-to-
tail configuration prevents the interaction of ICP27 with RNA
polymerase II (45). It is tempting to speculate that certain post-
translational modifications of ICP27 during infection, such as
its phosphorylation and arginine methylation (58, 82), could
direct such changes in conformation. This conformational
alteration may promote specificity and/or preference for cer-
tain partner proteins, such asNup62 orTAP, especially because
both of these modifications are important for ICP27 export,
viral replication, and gene expression functions (83, 84). ICP27
alsomultimerizes via its C terminus, which could generate large
complexes, resulting in increased binding sites available for
Nup62 and/or transport receptors. The study of the relation-
ship between ICP27 structural conformations and regulation of
binding partners will be an important area for future work.
RNA viruses that replicate exclusively in the cytoplasm block
host transport completely (e.g. by active degradation of Nup62
and Nup153 in poliovirus and rhinovirus-infected cells). In
contrast, ICP27 appears to dominantly utilize the host trans-
port machinery in support of export of intronless viral mRNAs
and import of viral regulatory and capsid and tegument pro-
teins for assembly in the nucleoplasm. Consistent with this and
an earlier study of NPC component localization during herpes-
virus infection (66), we found Nup62 protein intact and prop-
erly localized in HSV-1-infected cells, and an ICP27 mutant
deficient for Nup62 binding failed to inhibit cellular nucleocy-
toplasmic transport pathways. It will be interesting in the future
to test for ICP27 interactions with other Nups.
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